Published by Iain Gilbert on 24th February 2026
(Sharecast News) - Contract development and manufacturing firm Oxford Biomedica said on Tuesday that it expects to report a strong rise in full year revenues, but signalled that underlying profitability would only be modest despite a one‑off boost from its US acquisition.
URL: http://www.digitallook.com/dl/news/story/35718023/...